Literature DB >> 16201259

Methylation of gene CHFR promoter in acute leukemia cells.

Hui Gong1, Wengli Liu, Jianfeng Zhou, Huizhen Xu.   

Abstract

In order to explore whether gene CHFR was inactivated by methylation in leukemia cells, the expression of CHFR was examined before and after treatment with demethylation agent in Molt-4, Jurkat and U937 leukemia cell lines by means of RT-PCR. The methylation of promoter in Molt-4, Jurkat and U937 cells as well as 41 acute leukemia patients was analyzed by MS-PCR. The results showed that methylation of CHFR promoter was inactivated and could be reversed by treatment with a demethylating agent in Molt-4, Jurkat and U937. CHFR promoter methylation was detected in 39% of acute leukemia patients. There was no difference in incidence of CHFR promoter methylation between acute myelocytic leukemia and acute lymphocytic leukemia. In conclusion, CHFR is frequently inactivated in acute leukemia and is a good candidate for the leukemia supper gene. By affecting mitotic checkpoint function, CHFR inactivation likely plays a key role in tumorigenesis in acute leukemia. Moreover, the methylation of gene CHFR appears to be a good index with which to predict the sensitivity of acute leukemia to microtubule inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16201259     DOI: 10.1007/bf02828130

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  6 in total

1.  Chfr defines a mitotic stress checkpoint that delays entry into metaphase.

Authors:  D M Scolnick; T D Halazonetis
Journal:  Nature       Date:  2000-07-27       Impact factor: 49.962

2.  Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer.

Authors:  Yasuyuki Shibata; Nobuhiro Haruki; Yoshiyuki Kuwabara; Hideyuki Ishiguro; Noriyuki Shinoda; Atsushi Sato; Masahiro Kimura; Hiroshi Koyama; Tatsuya Toyama; Tadashi Nishiwaki; Junzo Kudo; Yukio Terashita; Shigeru Konishi; Hironori Sugiura; Yoshitaka Fujii
Journal:  Carcinogenesis       Date:  2002-10       Impact factor: 4.944

3.  Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers.

Authors:  Kotaro Mizuno; Hirotaka Osada; Hiroyuki Konishi; Yoshio Tatematsu; Yasushi Yatabe; Tetsuya Mitsudomi; Yoshitaka Fujii; Takashi Takahashi
Journal:  Oncogene       Date:  2002-04-04       Impact factor: 9.867

4.  Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer.

Authors:  Paul G Corn; Matthew K Summers; Franz Fogt; Arvind K Virmani; Adi F Gazdar; Thanos D Halazonetis; Wafik S El-Deiry
Journal:  Carcinogenesis       Date:  2003-01       Impact factor: 4.944

Review 5.  Cell cycle regulatory E3 ubiquitin ligases as anticancer targets.

Authors:  Todd R Pray; Francesco Parlati; Jianing Huang; Brian R Wong; Donald G Payan; Mark K Bennett; Sarkiz Daniel Issakani; Susan Molineaux; Susan D Demo
Journal:  Drug Resist Updat       Date:  2002-12       Impact factor: 18.500

6.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

  6 in total
  2 in total

1.  CHFR: A Novel Mitotic Checkpoint Protein and Regulator of Tumorigenesis.

Authors:  Lisa M Privette; Elizabeth M Petty
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

2.  Checkpoint with forkhead-associated and ring finger promoter hypermethylation correlates with microsatellite instability in gastric cancer.

Authors:  Eiji Oki; Yan Zhao; Rintaro Yoshida; Takanobu Masuda; Koji Ando; Masahiiko Sugiyama; Eriko Tokunaga; Masaru Morita; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  World J Gastroenterol       Date:  2009-05-28       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.